When patients switched to either fostemsavir or the combination of dolutegravir/lamivudine (DTG/3TC), suppression was maintained in most patients. Both dolutegravir ...
Newborns remain one of the most overlooked populations in the fight against HIV, with an estimated 120,000 new infections ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback